Kazia Therapeutics (KZIA) Shares Outstanding (2009 - 2025)

Kazia Therapeutics (KZIA) has 9 years of Shares Outstanding (Entity) data on file, last reported at $15.6 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) fell 63.3% year-over-year to $15.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.6 million (down 63.3% YoY) and the FY2023 annual result came in at $7371.0, up 39.1% from the prior year.
• Shares Outstanding (Entity) declined to $15.6 million in Q4 2025, from $42.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $42.5 million in Q4 2024 to a low of $4707.0 in Q2 2021.
• A 5-year average of $7.3 million and a median of $6598.5 in 2022 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 443187.91% — and 2025, when it plunged 63.3%.
• Tracing KZIA's Shares Outstanding (Entity) over 5 years: stood at $5281.0 in 2021, then rose by 10.32% to $5826.0 in 2022, then soared by 64.62% to $9591.0 in 2023, then surged by 443187.91% to $42.5 million in 2024, then sank by 63.3% to $15.6 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $15.6 million (Q4 2025), $42.5 million (Q4 2024), and $9591.0 (Q4 2023), per Business Quant data.